There are currently no randomised controlled trials evaluating GLP-1 receptor agonists as a treatment for rheumatoid arthritis, and these medications are not licensed or recommended for this indication by the MHRA, NICE, or the European Medicines Agency (EMA)
Among the outcome estimates, significant reductions were reported in 13 of 17 for major adverse cardiovascular events (MACE), 5 of 8 for cardiovascular mortality, 3 of 4 for cardiovascular disease (CVD) events, 1 of 3 for cardiovascular death, and 1 of 1 for composite cardiovascular outcomes
Seven mistakes that sabotage your GLP-1 smoothies Making a bad smoothie on a GLP-1 medication is worse than making no smoothie at all
Does the molecular weight of hyaluronic acid affect bloating risk
Recommended it to my mom and aunt, and theyre pleased too